---
figid: PMC8804138__43141_2022_297_Fig1_HTML
pmcid: PMC8804138
image_filename: 43141_2022_297_Fig1_HTML.jpg
figure_link: /pmc/articles/PMC8804138/figure/Fig1/
number: Fig. 1
figure_title: ''
caption: Hyperglycemia-mediated activation of various biochemical pathways. Reactive
  oxygen species generated due to hyperglycemia increase the transcription of various
  downstream signalling pathways by damaging the structure of DNA. This halts the
  normal pathway of glycolysis so that its substrates are diverted to other biochemical
  pathways. Glyceraldehyde 3 phosphate isomerizes to dihydroxyacetone phosphate (DHAP)
  that increases the production of advanced glycation end products. Activation of
  the hexosaminase pathway causes increased o glycosylation of glycolytic substrates.
  Activation of pyruvate kinase pathway, especially pyruvate kinase beta and NFAT
  pathway upregulation causes further activation of cytokines, chemokines, and interleukins,
  having deleterious effects on the cells of the retina, all of which is responsible
  for the changes of diabetic retinopathy. Activation of the polyol pathway leads
  to increased production of sorbitol and fructose, which are hyperosmotic agents
  and are implicated in the causation of diabetic cataract. As glyoxylase enzyme is
  generally overexpressed in the endothelium, AGE accumulation in the vessel wall
  is less. However, this detoxification system is deficient in people with diabetes,
  causing more pericyte apoptosis and thus accentuating DR pathology
article_title: 'Single nucleotide variants of receptor for advanced glycation end-products
  (AGER) gene: is it a new opening in the risk assessment of diabetic retinopathy?â€”a
  review.'
citation: Pragya Ahuja, et al. J Genet Eng Biotechnol. 2022 Dec;20:17.
year: '2022'

doi: 10.1186/s43141-022-00297-5
journal_title: Journal of Genetic Engineering & Biotechnology
journal_nlm_ta: J Genet Eng Biotechnol
publisher_name: Springer Berlin Heidelberg

keywords:
- Receptor for advanced glycation end products (AGER), single nucleotide variants
  (SNV), diabetic retinopathy
- Gene marker
- Risk factor

---
